259 related articles for article (PubMed ID: 16982748)
1. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis.
Liao J; Schneider A; Datta NS; McCauley LK
Cancer Res; 2006 Sep; 66(18):9065-73. PubMed ID: 16982748
[TBL] [Abstract][Full Text] [Related]
2. Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor.
Saidak Z; Boudot C; Abdoune R; Petit L; Brazier M; Mentaverri R; Kamel S
Exp Cell Res; 2009 Jul; 315(12):2072-80. PubMed ID: 19285978
[TBL] [Abstract][Full Text] [Related]
3. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
Dalrymple S; Antony L; Xu Y; Uzgare AR; Arnold JT; Savaugeot J; Sokoll LJ; De Marzo AM; Isaacs JT
Cancer Res; 2005 Oct; 65(20):9269-79. PubMed ID: 16230388
[TBL] [Abstract][Full Text] [Related]
4. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells.
Sun YH; Gao X; Tang YJ; Xu CL; Wang LH
J Androl; 2006; 27(5):671-8. PubMed ID: 16728719
[TBL] [Abstract][Full Text] [Related]
5. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
6. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.
Lecrone V; Li W; Devoll RE; Logothetis C; Farach-Carson MC
Cell Calcium; 2000 Jan; 27(1):35-42. PubMed ID: 10726209
[TBL] [Abstract][Full Text] [Related]
7. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
9. The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts.
Peiris D; Pacheco I; Spencer C; MacLeod RJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G753-66. PubMed ID: 17138967
[TBL] [Abstract][Full Text] [Related]
10. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
Lin DL; Tarnowski CP; Zhang J; Dai J; Rohn E; Patel AH; Morris MD; Keller ET
Prostate; 2001 May; 47(3):212-21. PubMed ID: 11351351
[TBL] [Abstract][Full Text] [Related]
11. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
Xiao D; Chinnappan D; Pestell R; Albanese C; Weber HC
Cancer Res; 2005 Nov; 65(21):9934-42. PubMed ID: 16267018
[TBL] [Abstract][Full Text] [Related]
12. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
13. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
Dubi N; Gheber L; Fishman D; Sekler I; Hershfinkel M
Carcinogenesis; 2008 Sep; 29(9):1692-700. PubMed ID: 18310092
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.
Sun B; Zhang X; Talathi S; Cummings BS
J Pharmacol Exp Ther; 2008 Jul; 326(1):59-68. PubMed ID: 18441250
[TBL] [Abstract][Full Text] [Related]
15. Calbindin-D28k and calcium sensing receptor cooperate in MCF-7 human breast cancer cells.
Parkash J; Chaudhry MA; Rhoten WB
Int J Oncol; 2004 May; 24(5):1111-9. PubMed ID: 15067332
[TBL] [Abstract][Full Text] [Related]
16. The extracellular calcium-sensing receptor (CaSR) on human esophagus and evidence of expression of the CaSR on the esophageal epithelial cell line (HET-1A).
Justinich CJ; Mak N; Pacheco I; Mulder D; Wells RW; Blennerhassett MG; MacLeod RJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G120-9. PubMed ID: 17962359
[TBL] [Abstract][Full Text] [Related]
17. Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells.
Chen SJ; Karan D; Johansson SL; Lin FF; Zeckser J; Singh AP; Batra SK; Lin MF
Prostate; 2007 Apr; 67(5):557-71. PubMed ID: 17221842
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
[TBL] [Abstract][Full Text] [Related]
19. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
20. Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells.
Sekine Y; Koike H; Nakano T; Nakajima K; Suzuki K
Clin Chim Acta; 2007 Aug; 383(1-2):78-84. PubMed ID: 17512923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
